Advances in the Treatment of Autoimmune Diseases; Cellular Activity, Type-1/Type-2 Cytokine Secretion Patterns and their Modulation by Therapeutic Peptides

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|13|1537-1550

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.13, 2005-06, pp. : 1537-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Peptides under Development for the Treatment of Type 1 and Type 2 Diabetes Mellitus

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 1, 2002-04 ,pp. : 63-82

Bentham Science Publishers

Access to resources Recommend Favorite

The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases

By  

Drug Design Reviews - Online, Vol. 1, Iss. 1, 2004-01 ,pp. : 53-74

Bentham Science Publishers

Access to resources Recommend Favorite

Peptides as Therapeutic Agents or Drug Leads for Autoimmune, Hormone Dependent and Cardiovascular Diseases

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 4, 2008-12 ,pp. : 294-306

Bentham Science Publishers

Access to resources Recommend Favorite

Type I IFNs and their role in the development of autoimmune diseases

By Burdick Laura M   Somani Najwa   Somani Ally-Khan  

Expert Opinion on Drug Safety, Vol. 8, Iss. 4, 2009-07 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite

Effects of NMDA Receptor Modulation on Hippocampal Type 2 Theta Activity in Rats

By Pitkanen M.   Sirvio J.   Ylinen A.   Koivisto E.   Riekkinen P.  

General Pharmacology, Vol. 26, Iss. 5, 1995-09 ,pp. : 1065-1070

Elsevier

Access to resources Recommend Favorite